In draining lymph nodes (dLNs), there was a small percentage of GPR171-positive T cells, which were presumably tumor-reactive T cells; over half of intratumoral T cells, including both CD4+ and CD8+ T-cell subsets, expressed GPR171 (Fig. 4a). This evidence concerns the gene CD4 and neoplasm.